Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Takenaka Corporation is a leading Japanese architecture, engineering, and construction firm that serves as a critical infrastructure partner for the global life sciences and healthcare industries. The company specializes in the design and construction of high-tech facilities, including state-of-the-art hospitals, research laboratories, and GMP-compliant cleanrooms. Notably, Takenaka is a pioneer in developing Cell Processing Centers (CPCs) essential for the regenerative medicine sector and is an active member of the Forum for Innovative Regenerative Medicine (FIRM). The firm also integrates "Bio-Digital" technologies to create smart healthcare environments and offers "Lab-as-a-Service" solutions to support biotechnology startups and pharmaceutical R&D. Its expertise ensures the rigorous environmental controls required for advanced therapeutic development and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Takenaka.